Mirae Asset Global Etfs Holdings Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 209,464 shares of ARWR stock, worth $3.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
209,464
Previous 231,539
9.53%
Holding current value
$3.9 Million
Previous $6.02 Million
32.61%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ARWR
# of Institutions
294Shares Held
90.8MCall Options Held
155KPut Options Held
426K-
Black Rock Inc. New York, NY15.7MShares$292 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$228 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$165 Million2.59% of portfolio
-
State Street Corp Boston, MA6.35MShares$118 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.89MShares$90.9 Million1.49% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.97B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...